Californium-252 Brachytherapy Combined With External-Beam Radiotherapy for Cervical Cancer: Long-Term Treatment Results

Purpose To observe, by retrospective analysis, the curative effects and complications due to californium-252 (252 Cf) neutron intracavitary brachytherapy (ICBT) combined with external-beam radiotherapy (EBRT) in the treatment of cervical cancer. Methods and Materials From February 1999 to December 2...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of radiation oncology, biology, physics Vol. 81; no. 5; pp. 1264 - 1270
Main Authors Lei, Xin, M.D., Ph.D, Qian, Cheng-Yuan, M.Sc, Qing, Yi, M.D, Zhao, Ke-Wei, M.D, Yang, Zheng-Zhou, M.D., Ph.D, Dai, Nan, M.D, Zhong, Zhao-Yang, M.D, Tang, Cheng, M.Sc, Li, Zheng, M.Sc, Gu, Xian-Qing, M.Sc, Zhou, Qian, M.Sc, Feng, Yan, M.Sc, Xiong, Yan-Li, M.Sc, Shan, Jin-Lu, M.D, Wang, Dong, M.D., Ph.D
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.12.2011
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Purpose To observe, by retrospective analysis, the curative effects and complications due to californium-252 (252 Cf) neutron intracavitary brachytherapy (ICBT) combined with external-beam radiotherapy (EBRT) in the treatment of cervical cancer. Methods and Materials From February 1999 to December 2007, 696 patients with cervical cancer (Stages IB to IIIB) were treated with252 Cf-ICBT in combination of EBRT. Of all, 31 patients were at Stage IB, 104 at IIA, 363 at IIB, 64 at IIIA, and 134 at IIIB. Californium-252 ICBT was delivered at 7–12 Gy per insertion per week, with a total dose of 29–45 Gy to reference point A in three to five insertions. The whole pelvic cavity was treated with 8-MV X-ray external irradiation at 2 Gy per fraction, four times per week. After 16–38 Gy of external irradiation, the center of the whole pelvic field was blocked with a 4-cm-wide lead shield, with a total external irradiation dose of 44–56 Gy. The total treatment course was 5 to 6 weeks. Results Overall survival rate at 3 and 5 years for all patients was 76.0% and 64.9%, respectively. Disease-free 3- and 5-year survival rates of patients were 71.2% and 58.4%, respectively. Late complications included vaginal contracture and adhesion, radiation proctitis, radiation cystitis, and inflammatory bowel, which accounted for 5.8%, 7.1%, 6.2%, and 4.9%, respectively. Univariate analysis results showed significant correlation of stage, age, histopathologic grade, and lymph node status with overall survival. Cox multiple regression analysis showed that the independent variables were stage, histopathologic grade, tumor size, and lymphatic metastasis in all patients. Conclusion Results of this series suggest that the combined use of252 Cf-ICBT with EBRT is an effective method for treatment of cervical cancer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0360-3016
1879-355X
DOI:10.1016/j.ijrobp.2010.08.039